MetaCap

Vivani Medical Inc. (VANI)

NASDAQ: VANIHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

1.14+0.05 (+4.59%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

VANI stock chart

Technical analysis

Key statistics

All statistics
Market cap
$102.83M
EPS (TTM)
-$0.33
52-week range
0.80 – 1.66
Day range
1.10 – 1.16
Volume / Avg
448.60K / 228.83K
Beta
—

52-week range

$0.80$1.66

VANI stock today

Vivani Medical (VANI) closed at $1.14 on Nov 20, up 4.59% (+$0.05), versus the S&P 500's 3.70% decline. At this level, VANI sits in the middle of its 52-week range of $0.80 to $1.66: 31.4% below the high, set on Jul 9, 2026 and 42.5% above the low. VANI is down 7.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 13.6%.

Vivani Medical has posted a net loss over the last twelve months (EPS of -$0.33), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Vivani Medical

Company profile

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs.

Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
CEO
Dr. Adam Mendelsohn Ph.D.
Headquarters
Alameda, CA
Employees
42
IPO year
2014
Website
vivani.com

Financial highlights

Full financials

In fiscal 2025, Vivani Medical generated $0 in revenue, up 0.0% from fiscal 2024. Vivani Medical reported a net loss of $26.6 million, compared with a loss of $23.5 million a year earlier. Diluted earnings per share came in at -$0.43.

Vivani Medical annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$0$0———
Growth—————
Net income$-26.61M$-23.49M$-25.65M$-13.89M$-12.77M
EPS (diluted)$-0.43$-0.43$-0.50—$-0.27

Analyst forecast

Forecast

Consensus (3 analysts)

strong_buy

Avg. price target

$3.83+235.96%

  • Strong buy 1
  • Buy 2
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $3.50High $4.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 11, 2026
EPS actual vs est.
$-0.08 vs —

VANI news

All VANI news

Vivani Medical peers

Health Care sector
VANI peer companies
CompanyPrice% ChgMarket capCompare
STXSStereotaxis Inc.0.9422-6.71%$95.03Mvs VANI
HSDTSolana Company Class A1.49-10.24%$93.70Mvs VANI
FOCLEDAP TMS S.A. ADR2.61-7.45%$123.25Mvs VANI
NRXSNeuraxis Inc.4.22-6.22%$59.90Mvs VANI
HYPRHyperfine Inc. Class A0.5465+4.27%$57.96Mvs VANI
OMOutset Medical Inc.2.81-3.44%$53.03Mvs VANI
POCIPrecision Optics Corporation Inc.4.12+1.41%$45.30Mvs VANI
ECORelectroCore Inc.4.42-8.87%$40.78Mvs VANI

Indexes, lists and sector

Vivani Medical stock FAQ

What is Vivani Medical's stock price today?

VANI last traded at $1.14 as of Nov 20, 4:00 PM EST, up 4.59% on the day. Prices are delayed at least 15 minutes.

Does Vivani Medical pay a dividend?

No. Vivani Medical does not currently pay a regular cash dividend.

Who is Vivani Medical's CEO?

Dr. Adam Mendelsohn Ph.D. is the chief executive officer of Vivani Medical Inc., which has about 42 employees.

Has VANI ever split its stock?

Yes. The most recent VANI stock split was a 1-for-3 split on Aug 19, 2022, one of 2 splits on record.

What is the VANI 52-week high?

The 52-week high for VANI is $1.66 and the 52-week low is $0.80. The stock is currently 31.4% below its high.

Compare VANI